Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis

ClinicalTrials.gov ID: NCT02376790

Public ClinicalTrials.gov record NCT02376790. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 13, 2026, 11:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter Double-Blind, Randomized Controlled Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects With Psoriatic Arthritis

Study identification

NCT ID
NCT02376790
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
851 participants

Conditions and interventions

Interventions

  • Etanercept Drug
  • Methotrexate Drug
  • Placebo to Etanercept Drug
  • Placebo to Methotrexate Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2, 2015
Primary completion
Jan 8, 2018
Completion
Jul 5, 2018
Last update posted
Sep 20, 2022

2015 – 2018

United States locations

U.S. sites
55
U.S. states
26
U.S. cities
53
Facility City State ZIP Site status
Research Site Tuscaloosa Alabama 35406
Research Site Glendale Arizona 85306
Research Site Mesa Arizona 85202
Research Site Scottsdale Arizona 85258
Research Site Little Rock Arkansas 72205
Research Site Escondido California 92025
Research Site Hemet California 92543
Research Site Los Angeles California 90095
Research Site Mather California 95655
Research Site Palm Desert California 92260
Research Site San Francisco California 94143
Research Site Santa Monica California 90404
Research Site Thousand Oaks California 91360
Research Site Tustin California 92780
Research Site Aventura Florida 33180
Research Site Clearwater Florida 33765
Research Site Kissimmee Florida 34741
Research Site Ocoee Florida 34761
Research Site Tampa Florida 33609
Research Site Tampa Florida 33613
Research Site Zephyrhills Florida 33542
Research Site Meridian Idaho 83642
Research Site Chicago Illinois 60611
Research Site Springfield Illinois 62703
Research Site Bowling Green Kentucky 42101
Research Site Paducah Kentucky 42003
Research Site Frederick Maryland 21702
Research Site Hagerstown Maryland 21740
Research Site Wheaton Maryland 20902
Research Site Worcester Massachusetts 01605
Research Site Lansing Michigan 48910
Research Site Lansing Michigan 48917
Research Site Saint Clair Shores Michigan 48081
Research Site Rochester Minnesota 55905
Research Site Las Vegas Nevada 89128
Research Site Lebanon New Hampshire 03756
Research Site Clifton New Jersey 07012
Research Site Freehold New Jersey 07728
Research Site Albuquerque New Mexico 87102
Research Site New York New York 10016
Research Site Rochester New York 14642
Research Site Asheville North Carolina 28803
Research Site Charlotte North Carolina 28204
Research Site Cleveland Ohio 44109
Research Site Oklahoma City Oklahoma 73103
Research Site Duncansville Pennsylvania 16635
Research Site Wyomissing Pennsylvania 19610
Research Site Charleston South Carolina 29406
Research Site Rapid City South Dakota 57701
Research Site Dallas Texas 75231
Research Site San Antonio Texas 78232
Research Site Chesapeake Virginia 23320
Research Site Danville Virginia 24541
Research Site Roanoke Virginia 24016
Research Site Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 83 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02376790, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 20, 2022 · Synced May 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02376790 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →